CORDIS
EU research results

CORDIS
English EN

Impact of exposome on the course of lung diseases

Project information

Grant agreement ID: 874753

Status

Ongoing project

  • Start date

    1 January 2020

  • End date

    31 December 2024

Funded under:

H2020-EU.3.1.2.

  • Overall budget:

    € 11 134 616,25

  • EU contribution

    € 11 134 616,25

Coordinated by:

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

Project description

DE EN ES FR IT PL
English EN

Exposing the impact of environmental factors on debilitating lung disease

The concept of exposome reflects the cumulative measure of environmental influences and associated biological responses from the perinatal period onwards, including exposures from the environment, diet, behavior and endogenous processes. Its importance to health and disease is undeniable, particularly for chronic respiratory diseases, as they are the leading causes of environment-related deaths. Chronic obstructive pulmonary disease and cystic fibrosis are two highly debilitating chronic respiratory diseases sharing common characteristics, yet presenting opposite roots: the former appears to be intricately related to the exposome while the latter not. To address the impact of exposome on the course of these two diseases, the EU-funded REMEDIA project is developing approaches combining the collection of exposome and clinical data, advanced machine learning, the use of atmospheric simulation chambers, and the development of individual sensor devices. Such approach could point the way to effective prevention and treatment.

Programme(s)

H2020-EU.3.1.2. - Preventing disease

Topic(s)

SC1-BHC-28-2019 - The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health

Call for proposal

H2020-SC1-2019-Single-Stage-RTD

See other projects for this call

Funding Scheme

RIA - Research and Innovation action
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

Address

Rue De Tolbiac 101
75654 Paris

France

Activity type

Research Organisations

EU Contribution

€ 2 332 877,50

Website

Contact the organisation

Participants (13)

UNIVERSITE DE PARIS

France

EU Contribution

€ 1 672 881,25

UNIVERSITE PARIS DIDEROT - PARIS 7

France

CENTRE HOSPITALIER INTERCOMMUNAL DE CRETEIL

France

EU Contribution

€ 628 315

KRAEFTENS BEKAEMPELSE

Denmark

EU Contribution

€ 258 556,25

DATA MINING INTERNATIONAL SA

Switzerland

EU Contribution

€ 777 500

LAURENT NIDDAM EUROPAI KOZOSSEGI JOGASZ IRODA

Hungary

EU Contribution

€ 207 500

CAMBRIDGE EPIGENETIX LIMITED

United Kingdom

EU Contribution

€ 1 037 694

LIPOTYPE

Germany

EU Contribution

€ 731 250

FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V.

Germany

EU Contribution

€ 1 611 674,50

IDRYMA TECHNOLOGIAS KAI EREVNAS

Greece

EU Contribution

€ 462 500

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

EU Contribution

€ 625 750

UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET

Norway

EU Contribution

€ 345 617,50

INSERM TRANSFERT SA

France

EU Contribution

€ 442 500,25

Project information

Grant agreement ID: 874753

Status

Ongoing project

  • Start date

    1 January 2020

  • End date

    31 December 2024

Funded under:

H2020-EU.3.1.2.

  • Overall budget:

    € 11 134 616,25

  • EU contribution

    € 11 134 616,25

Coordinated by:

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

Download

PDF XML

Last update: 29 February 2020

Record number: 226542